Terbinafine subungual - Hallux

Drug Profile

Terbinafine subungual - Hallux

Alternative Names: HTS-519

Latest Information Update: 05 Aug 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Hallux
  • Class Antifungals; Naphthalenes; Small molecules
  • Mechanism of Action Cell membrane modulators; Squalene monooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Onychomycosis

Most Recent Events

  • 01 Jul 2016 Phase-II clinical trials in Onychomycosis in USA (Implant) (NCT02798380)
  • 08 Jun 2016 Hallux plans a phase II trial for Onchomycosis in USA (NCT02798380)
  • 16 Dec 2015 Clinical trials in Onychomycosis in USA (Implant)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top